Abacavir And Lamivudine Tablet, Film Coated
Product Images NDC 42385-962

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abacavir And Lamivudine (NDC 42385-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Container Label (30's count))

These are tablets that contain abacavir sulfate and lamivudine USP, with each film-coated tablet containing 600mg and 300mg respectively. Dosage information is available in the prescribing information. The tablets should be stored between 20° to 25°C (68° to 77°F), with a controlled room temperature excursion range of 15° to 30°C (59° to 86°F). Abacavir and Lamivudine Tablets are dispensed in 30 tablet packs and patients should be given a medication guide and warning card with every dosage. The manufacturer is Laurus Labs Limited in Visakhapatnam-531011, India.*

FDA Label Image

Abacavir Structure (Al Structure 1)

FDA Label Image

Lamivudine Structure (Al Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.